MCK
Price
$714.88
Change
-$6.87 (-0.95%)
Updated
Jun 3 closing price
Capitalization
70.55B
56 days until earnings call
SNYR
Price
$2.07
Change
+$0.31 (+17.61%)
Updated
Jun 3 closing price
Capitalization
494.39K
Interact to see
Advertisement

MCK vs SNYR

Header iconMCK vs SNYR Comparison
Open Charts MCK vs SNYRBanner chart's image
McKesson
Price$714.88
Change-$6.87 (-0.95%)
Volume$822.31K
Capitalization70.55B
Synergy CHC
Price$2.07
Change+$0.31 (+17.61%)
Volume$218.94K
Capitalization494.39K
MCK vs SNYR Comparison Chart
Loading...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCK vs. SNYR commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCK is a Buy and SNYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (MCK: $714.88 vs. SNYR: $2.07)
Brand notoriety: MCK: Notable vs. SNYR: Not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MCK: 73% vs. SNYR: 14%
Market capitalization -- MCK: $70.55B vs. SNYR: $494.39K
MCK [@Medical Distributors] is valued at $70.55B. SNYR’s [@Medical Distributors] market capitalization is $494.39K. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCK’s FA Score shows that 3 FA rating(s) are green whileSNYR’s FA Score has 0 green FA rating(s).

  • MCK’s FA Score: 3 green, 2 red.
  • SNYR’s FA Score: 0 green, 5 red.
According to our system of comparison, MCK is a better buy in the long-term than SNYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCK’s TA Score shows that 2 TA indicator(s) are bullish while SNYR’s TA Score has 2 bullish TA indicator(s).

  • MCK’s TA Score: 2 bullish, 6 bearish.
  • SNYR’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both MCK and SNYR are a bad buy in the short-term.

Price Growth

MCK (@Medical Distributors) experienced а -0.67% price change this week, while SNYR (@Medical Distributors) price change was +16.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.95%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was -4.99%.

Reported Earning Dates

MCK is expected to report earnings on Jul 30, 2025.

SNYR is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Medical Distributors (-1.95% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($70.5B) has a higher market cap than SNYR($494K). MCK YTD gains are higher at: 25.701 vs. SNYR (-52.955). MCK has higher annual earnings (EBITDA): 4.44B vs. SNYR (-8.26M). MCK has more cash in the bank: 1.98B vs. SNYR (315K). SNYR has less debt than MCK: SNYR (5.8M) vs MCK (7.61B). MCK has higher revenues than SNYR: MCK (302B) vs SNYR (26M).
MCKSNYRMCK / SNYR
Capitalization70.5B494K14,271,255%
EBITDA4.44B-8.26M-53,745%
Gain YTD25.701-52.955-49%
P/E Ratio24.25N/A-
Revenue302B26M1,161,538%
Total Cash1.98B315K629,206%
Total Debt7.61B5.8M131,172%
FUNDAMENTALS RATINGS
MCK vs SNYR: Fundamental Ratings
MCK
SNYR
OUTLOOK RATING
1..100
7572
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
585
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3234
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (12) in the Medical Distributors industry is somewhat better than the same rating for SNYR (56) in the null industry. This means that MCK’s stock grew somewhat faster than SNYR’s over the last 12 months.

MCK's Profit vs Risk Rating (5) in the Medical Distributors industry is significantly better than the same rating for SNYR (85) in the null industry. This means that MCK’s stock grew significantly faster than SNYR’s over the last 12 months.

MCK's SMR Rating (100) in the Medical Distributors industry is in the same range as SNYR (100) in the null industry. This means that MCK’s stock grew similarly to SNYR’s over the last 12 months.

MCK's Price Growth Rating (32) in the Medical Distributors industry is in the same range as SNYR (34) in the null industry. This means that MCK’s stock grew similarly to SNYR’s over the last 12 months.

MCK's P/E Growth Rating (100) in the Medical Distributors industry is in the same range as SNYR (100) in the null industry. This means that MCK’s stock grew similarly to SNYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCKSNYR
RSI
ODDS (%)
Bearish Trend 2 days ago
51%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 19 days ago
70%
Declines
ODDS (%)
Bearish Trend 13 days ago
41%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BARK1.310.07
+5.65%
BARK
STE243.331.25
+0.52%
STERIS plc
SGRY23.28-0.11
-0.47%
Surgery Partners
NEXA4.95-0.07
-1.39%
Nexa Resources SA
SGLY0.92-0.07
-7.53%
Singularity Future Technology Ltd

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and COSM have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
+17.61%
COSM - SNYR
17%
Poorly correlated
-0.22%
ZYXI - SNYR
-1%
Poorly correlated
+5.94%
CAH - SNYR
-3%
Poorly correlated
+0.15%
HSIC - SNYR
-7%
Poorly correlated
+1.45%
MCK - SNYR
-7%
Poorly correlated
-0.95%
More